Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force
Wolff T, Miller T, Ko S
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Synthesis No 68. 2009
Authors' objectives
To determine the benefits and harms of taking aspirin for the primary prevention of myocardial infarctions, strokes, and death.
Authors' conclusions
Aspirin reduces the risk of myocardial infarctions in men and strokes in women. The risk of serious bleeding is increased with aspirin use.